Loading…
MoonLake Immunotherapeutics is projected to rise to $29.40 by 2027, a +44% move from its current price of $20.36. MLTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $19.75 | $20.36 | $20.98 | -0.02% |
| Jul 13 | $19.51 | $20.35 | $21.24 | -0.03% |
| Jul 14 | $19.32 | $20.35 | $21.44 | -0.05% |
| Jul 15 | $19.16 | $20.35 | $21.61 | -0.07% |
| Jul 16 | $19.02 | $20.34 | $21.76 | -0.08% |
| Jul 17 | $18.89 | $20.34 | $21.89 | -0.10% |
| Jul 18 | $18.78 | $20.34 | $22.02 | -0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $18.78 | $20.34 | $22.02 | -0.12% |
| Week 2 | $18.15 | $20.31 | $22.73 | -0.23% |
| Week 3 | $17.68 | $20.29 | $23.29 | -0.35% |
| Week 4 | $17.28 | $20.27 | $23.76 | -0.47% |
| Week 5 | $16.94 | $20.24 | $24.18 | -0.58% |
| Week 6 | $16.64 | $20.22 | $24.57 | -0.70% |
| Week 7 | $16.36 | $20.19 | $24.93 | -0.81% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MoonLake Immunotherapeutics is a clinical-stage biotechnology company focused on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
MoonLake Immunotherapeutics is categorized in the Healthcare sector.
MoonLake Immunotherapeutics (MLTX) is currently priced at $20.00. It has a market cap of $1.49B and is ranked 2251 in market capitalization/scaling. The long-range price outlook is bullish, with a year-by-year forecast that shows continued upside from 2026 through 2050.
The 2026 forecast holds an average of $20.00, with later years showing pronounced upside: 2027 avg $31.57, 2028 avg $38.73, 2029 avg $48.52, 2030 avg $58.32, 2031 avg $59.40, 2032 avg $67.17, 2033 avg $79.20, 2034 avg $105.38, 2035 avg $131.48, 2040 avg $196.87, and 2050 avg $455.90, with a 2050 max of $980.63. The forecast also lists increasing ROIs, reaching 191.6 in 2030, 884.3 in 2040, and 2179.5 in 2050, with sentiment turning bullish after 2026.
A major floor 24.7% below — a decisive break under it would weaken the trend.
The nearest floor, 14.1% below — buyers have tended to step in here.
The nearest ceiling, 8.8% above — a clean break opens room to run.
A major ceiling 21.2% above — clearing it would confirm fresh momentum.
Key MLTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MLTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.48 | Buy | $19.73 | Buy |
| MA 10 | $19.47 | Buy | $19.59 | Buy |
| MA 20 | $19.56 | Buy | $19.38 | Buy |
| MA 50 | $18.48 | Buy | $18.75 | Buy |
| MA 100 | $18.06 | Buy | $18.57 | Buy |
| MA 200 | $16.32 | Buy | $21.42 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.68 | Neutral |
| Stoch RSI (14) | 45.42 | Neutral |
| CCI (20) | 76.33 | Neutral |
| Williams %R (14) | -54.88 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -4.05 | Sell |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 45.12 | Neutral |
| TRIX (15) | 0.29 | Buy |
| Awesome (5,34) | 0.44 | Buy |
| Ultimate (7,14,28) | 64.10 | Neutral |
| Momentum (10) | 0.37 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 19.76 | Buy |
| ADX (14) | 10.45 | Neutral |
| ATR (14) | 0.46 | Info |
The 30-day technical picture is bullish. RSI14 is 60, and the near-term momentum aligns with upside potential. The moving averages sit at $18.05 for SMA50 and $18.24 for SMA200, providing a constructive backdrop. The stock’s immediate framework shows support at $16.37 and resistance at $22.16, with a 30-day price range spanning $15.44 to $25.91.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.17 | $20.36 | $26.53 | 0% | Neutral | |
| $23.19 | $29.40 | $39.58 | +44% | Bullish | |
| $28.24 | $36.94 | $51.76 | +81% | Bullish | |
| $33.22 | $44.59 | $64.47 | +119% | Bullish | |
| $38.16 | $52.42 | $77.80 | +157% | Bullish | |
| $40.67 | $57.03 | $86.61 | +180% | Bullish | |
| $43.71 | $62.50 | $96.89 | +207% | Bullish | |
| $48.49 | $70.62 | $111.52 | +247% | Bullish | |
| $62.47 | $92.58 | $148.70 | +355% | Bullish | |
| $73.94 | $111.42 | $181.83 | +447% | Bullish | |
| $104.62 | $170.16 | $296.64 | +736% | Bullish | |
| $203.27 | $377.68 | $724.54 | +17.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $11.17 | $20.36 | $24.44 | +0.00% |
| August 2026 | $16.77 | $19.85 | $24.17 | -2.49% |
| September 2026 | $16.81 | $20.05 | $24.72 | +1.01% |
| October 2026 | $17.47 | $20.98 | $26.12 | +4.62% |
| November 2026 | $17.45 | $21.08 | $26.47 | +0.46% |
| December 2026 | $17.27 | $20.96 | $26.53 | -0.54% |
Click any year to see its month-by-month MLTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MLTX could reach as high as $26.53, with a base case around $20.36 and support toward $11.17 — roughly 0% from $20.36. Price action looks broadly range-bound.
Expect MLTX to range from $23.19 to $39.58 through 2027. The $29.40 average target implies a +44% move from current prices. That is up +44% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The MLTX price prediction for 2028 points to an average of $36.94 (low $28.24, high $51.76) — a potential gain of +81% on today's $20.36. Momentum favours further upside here.
In 2029, MLTX is projected to trade between $33.22 and $64.47, averaging $44.59 — a potential gain of +119% from today's $20.36. That is up +21% on the projected 2028 average. Buyers look set to stay in control over this stretch.
MoonLake Immunotherapeutics's 2030 outlook centres on $52.42, within a $38.16 to $77.80 range. That is up +18% on the projected 2029 average. That marks a +157% change versus current levels. Momentum favours further upside here.
By 2031, MLTX could reach as high as $86.61, with a base case around $57.03 and support toward $40.67 — roughly +180% from $20.36. Buyers look set to stay in control over this stretch.
Expect MLTX to range from $43.71 to $96.89 through 2032. The $62.50 average target implies a +207% move from current prices. That is up +10% on the projected 2031 average. Momentum favours further upside here.
The MLTX price prediction for 2033 points to an average of $70.62 (low $48.49, high $111.52) — a potential gain of +247% on today's $20.36. Buyers look set to stay in control over this stretch.
In 2034, MLTX is projected to trade between $62.47 and $148.70, averaging $92.58 — a potential gain of +355% from today's $20.36. That is up +31% on the projected 2033 average. Momentum favours further upside here.
MoonLake Immunotherapeutics's 2035 outlook centres on $111.42, within a $73.94 to $181.83 range. That is up +20% on the projected 2034 average. That marks a +447% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, MLTX could reach as high as $296.64, with a base case around $170.16 and support toward $104.62 — roughly +736% from $20.36. Momentum favours further upside here.
Expect MLTX to range from $203.27 to $724.54 through 2050. The $377.68 average target implies a +17.6x move from current prices. That is up +122% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MLTX today (≈ 49.115914 MLTX) could be worth
$18,550.24
+$17,550.24 (+1755%) by 2050 · US Dollar
Based on the average projected MLTX price of $377.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MLTXwould be worth at today's price.
$1,000 invested in MLTX on Jul 10, 2025 (≈ 20.458265 MLTX) would be worth
$416.53
-$583.47 (-58.3%) today · 0.42× · US Dollar
Based on a MLTX entry price of $48.88 vs. today's $20.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $18.95 | $1,074.41 | +7.4% |
| 1 month ago | $17.49 | $1,164.09 | +16.4% |
| 3 months ago | $17.96 | $1,133.63 | +13.4% |
| 6 months ago | $18.09 | $1,125.48 | +12.5% |
| 1 year ago | $48.88 | $416.53 | -58.3% |
| All time (5.0y) ago | $10.21 | $1,994.12 | +99.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MLTX forecast.
Our base-case forecast reaches $41.00 around 2029.
Implied market cap at $41.00: $3.43B
The multi-year forecast depicts a clear path of sustained upside from 2026 through 2050. The average price climbs from $20.00 in 2026 to progressively higher levels, with notable milestones such as $31.57 in 2027, $38.73 in 2028, $58.32 in 2030, $196.87 in 2040, and $455.90 in 2050. The associated ROIs rise from 0 in 2026 to 191.6 in 2030, 884.3 in 2040, and 2179.5 in 2050, with bullish sentiment indicated for 2027 onward.
The forecast also shows a 2050 max of $980.63. These are estimates and not guarantees, reflecting potential upside and the inherent uncertainties of a clinical-stage biotechnology company.
Tap a question to reveal the answer.
Avg $58.32, min $39.88, max $92.46, ROI 191.6, sentiment bullish.
The forecast shows bullish sentiment from 2027 onward with rising averages (2027 avg $31.57, 2028 $38.73, 2029 $48.52, 2030 $58.32, 2040 $196.87, 2050 $455.90) and ROI up to 2179.5; 2026 is neutral with avg $20.00. These are estimates, not guarantees.
No. The max forecast for 2050 is $980.63, which is below $1000.
Current price is $20.00 and market cap is $1.49B.
30-day range: low $15.44, high $25.91.
MoonLake Immunotherapeutics Community Discussion
0Share your MoonLake Immunotherapeutics price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.